POTENT ORAL ANTICONVULSANT ACTION OF CPP AND CPPENE IN DBA/2 MICE

被引:43
作者
CHAPMAN, AG
GRAHAM, J
MELDRUM, BS
机构
[1] Department of Neurology, Institute of Psychiatry, London, SES 8AF, De Crespigny Park
基金
英国医学研究理事会;
关键词
(DBA/2 mouse); Anticonvulsants; Epilepsy; NMDA receptor antagonists;
D O I
10.1016/0014-2999(90)94798-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CPP (3-(2-carboxypiperazine-4-yl)-1-phosphonate), and its unsaturated analogue, CPPene (3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid), have potent anticonvulsant activity against sound-induced clortic seizures in DBA/2 mice. Following i.p. adminstration the protection is maximal at 1-2 h, and the ED50, values (μ mol/kg) are: D(-)-CPPene, 1.54; D(-)-CPP, 2.75; D,L(±)-CPP, 4.36. Following oral administration the protection is maximal at 3-4 h and the ED50 (μ mol/kg) values are: D(-)-CPPene, 40,19: D(-)-CPP, 65.80; D,L(±)-CPP, 108.1. © 1990.
引用
收藏
页码:97 / 99
页数:3
相关论文
共 10 条
[1]  
AEBISCHER B, 1989, HELV CHIM ACTA, V72, P1
[2]   ANTICONVULSANT ACTION AND BIOCHEMICAL EFFECTS IN DBA 2 MICE OF CPP (3-((+/-)-2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONATE), A NOVEL N-METHYL-D-ASPARTATE ANTAGONIST [J].
CHAPMAN, AG ;
MELDRUM, BS ;
NANJI, N ;
WATKINS, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :91-96
[3]   NON-COMPETITIVE N-METHYL-D-ASPARTATE ANTAGONISTS PROTECT AGAINST SOUND-INDUCED SEIZURES IN DBA/2 MICE [J].
CHAPMAN, AG ;
MELDRUM, BS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) :201-211
[4]  
CHAPMAN AG, 1989, J CEREB BLOOD FLOW M, V9, pS309
[5]  
CHAPMAN AG, 1987, NEUROTRANSMITTERS EP
[6]   ANTICONVULSANT ACTION OF EXCITATORY AMINO-ACID ANTAGONISTS [J].
CROUCHER, MJ ;
COLLINS, JF ;
MELDRUM, BS .
SCIENCE, 1982, 216 (4548) :899-901
[7]   CPP, A NEW POTENT AND SELECTIVE NMDA ANTAGONIST - DEPRESSION OF CENTRAL NEURON RESPONSES, AFFINITY FOR [H-3] D-AP5 BINDING-SITES ON BRAIN MEMBRANES AND ANTICONVULSANT ACTIVITY [J].
DAVIES, J ;
EVANS, RH ;
HERRLING, PL ;
JONES, AW ;
OLVERMAN, HJ ;
POOK, P ;
WATKINS, JC .
BRAIN RESEARCH, 1986, 382 (01) :169-173
[8]  
HERRLING PL, 1989, 19TH ANN M NEUR PHOE
[9]  
LEHMANN J, 1987, J PHARMACOL EXP THER, V240, P737
[10]  
SCHMUTZ M, 1988, 18TH ANN M SOC NEUR